Ibrutinib is a compound used as an active pharmaceutical ingredient. It functions as a selective and covalent inhibitor of Bruton's tyrosine kinase and is employed in the manufacturing of pharmaceuticals for B-cell malignancies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ibrutinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ibrutinib acetyl impurity
pharmaceutical impurity standard
(R)-tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
pharmaceutical raw material
Tucatinib
pharmaceutical raw material
Pacritinib
pharmaceutical raw material
D-Pemetrexed disodium
pharmaceutical raw material
Roxatidine acetate hydrochloride
pharmaceutical raw material
Ibrutinib, (S)-
pharmaceutical raw material
PCI-32765 (Racemate)
pharmaceutical raw material
The international HS code for Ibrutinib (CAS 936563-96-1) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
XYFPWWZEPKGCCK-GOSISDBHSA-N
C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
Sourcing Ibrutinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.